A reaction rate of compound i can be expressed as: r_{H,i} = - frac{d[i]}{dt} = frac{{k_{H,i} [i]^{{n_{i} }} }}{{[i]_{o}^{{n_{i} - 1}} }} (21 where, r H,i : constant of reaction rate of compound i, [i] : the current concentration of compound i, [i]o : the concentration of compound i at initial time.
Abbreviations: I = pool I at initial presentation (n = 4); IIa = pool II at initial presentation (n = 2); IIb = pool II in hematological remission (n = 2).
For gait data, discrete parameters were measured as follows; knee angle in the sagittal plane (i) at initial contact, (ii) at peak knee flexion, and (iii) range of motion; hip angle in the frontal plane (i) at initial contact; knee moment in the frontal plane (i) at 1st peak, and (ii) mean during stance; and hip moment in the frontal plane (i) at 1st peak, and (ii) mean during stance.
Lung cancer patients appeared to be eligible for phase I trials at initial consultation visits, but many were recommended other treatments first, or had rapid deterioration after initially being eligible.
A simulation of this process is shown in Figure 5, and the slow linear increase of T i at the initial stage is clearly visible.
Although the remaining patients were stage I to III at initial diagnosis (without distant metastases) and had received curative surgery, most of them eventually suffered recurrence or resistance to conventional chemotherapy.
No statistically significant difference was observed in the incidence of TB disease among patients with baseline (i.e., at initial visit to the facility) WHO clinical stages 3 and 4 vs. 1 and 2, [HR 1.4; (95% CI 0.5, 3.6)].
Very early presentation was defined as presentation with AJCC stage I breast cancer at initial diagnosis, whereas more advanced presentation comprise AJCC stage II, stage III, or stage IV breast cancers.
The majority of tumor samples were of primary breast cancers (96%), invasive ductal carcinoma histology (89%), moderately to poorly differentiated (73%), stage I or II at initial diagnosis (71%), and hormone receptor status (estrogen receptor (ER)/progesterone receptor (PR)) positive (73%).
The pre-publication history for this paper can be accessed here: I metastasis detected at initial presentation, F metastasis detected during follow-up, DOD died of disease, AWD alive with disease, NED no evidence of disease, ARF acute renal failure, NS not specified.
where G = predicted basal area; G i = basal area at initial measurement; T = age of prediction; T i = age of initial measurement; a = asymptote parameter estimate; c = shape parameter estimate.
